par Agarwala, Vivek;Sen, Nibedita;Dent, Susan;Ghose, Aruni;Price, Elexis E.B.;Rickards, John;de Azambuja, Evandro 
;Brown, Sherry Ann
Référence Innovations in Cardio-Oncology: Artificial Intelligence, Digital Health, and Precision Medicine, Elsevier, page (31-67)
Publication Publié, 2025-01
;Brown, Sherry AnnRéférence Innovations in Cardio-Oncology: Artificial Intelligence, Digital Health, and Precision Medicine, Elsevier, page (31-67)
Publication Publié, 2025-01
Partie d'ouvrage collectif
| Résumé : | Cancer remains the second leading cause of death in developed as well as developing nations following cardiovascular diseases. It is projected that there will be 23.6 million new cancer cases annually worldwide by 2030. As new cancer therapies with potential cardiotoxicity are increasingly adopted into clinic practice, identifying, preventing, and managing cardiovascular health in patients with cancer will be crucial. The goal of cardio-oncology services is to offer specialized, multidisciplinary evaluation, and consistent coordinated care throughout the patient's journey. The objective is to prevent and monitor for cardiovascular complications, detect early and manage adverse effects when they occur, while empowering patients to minimize treatment interruptions and continue life prolonging yet potentially cardiotoxic cancer treatments, ensuring comprehensive care throughout. Cardio-oncology services also work to improve acute and long-term cardiovascular health for patients through primary and secondary prophylactic cardioprotective measures and coordinate ongoing medical education, training, and clinical research in cardio-oncology. The importance of cardio-oncology is increasingly being recognized among cardiologists and medical oncologists/hematologists, as well as radiation oncology and surgical oncology. |
